Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial.
Saved in:
| Title: | Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. |
|---|---|
| Authors: | Russell WE; 1Departments of Pediatrics and Cell & Developmental Biology, Vanderbilt University Medical Center, Nashville, TN., Bundy BN; 2Health Informatics Institute, University of South Florida, Tampa, FL., Anderson MS; 3Department of Medicine, University of California, San Francisco, San Francisco, CA.; 4Immune Tolerance Network, Seattle, WA., Cooney LA; 4Immune Tolerance Network, Seattle, WA., Gitelman SE; 5Diabetes Center, University of California, San Francisco, San Francisco, CA., Goland RS; 6Departments of Medicine and Pediatrics, Columbia University, New York, NY., Gottlieb PA; 7Barbara Davis Diabetes Center, University of Colorado, Anschutz, CO., Greenbaum CJ; 8Benaroya Research Institute, Seattle, WA., Haller MJ; 9Department of Pediatrics, University of Florida, Gainesville, FL., Krischer JP; 2Health Informatics Institute, University of South Florida, Tampa, FL., Libman IM; 10University of Pittsburgh, Pittsburgh, PA., Linsley PS; 8Benaroya Research Institute, Seattle, WA., Long SA; 8Benaroya Research Institute, Seattle, WA., Lord SM; 8Benaroya Research Institute, Seattle, WA., Moore DJ; 11Departments of Pediatrics and Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN., Moore WV; 12Children's Mercy Hospital, Kansas City, MO., Moran AM; 13Department of Pediatrics, University of Minnesota, Minneapolis, MN., Muir AB; 14Emory University, Atlanta, GA., Raskin P; 15University of Texas Southwestern, Dallas, TX., Skyler JS; 16Department of Medicine, University of Miami, Miami, FL., Wentworth JM; 17Royal Melbourne Hospital and The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia., Wherrett DK; 18Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Wilson DM; 19Stanford University, Stanford, CA., Ziegler AG; 20Forschergruppe Diabetes, Technical University Munich at Klinikum rechts der Isar, Munich, Germany.; 21Institute for Diabetes Research, Helmholtz Munich, German Center for Environmental Health, Munich, Germany., Herold KC; 22Yale University, New Haven, CT. |
| Corporate Authors: | Type 1 Diabetes TrialNet Study Group |
| Source: | Diabetes care [Diabetes Care] 2023 May 01; Vol. 46 (5), pp. 1005-1013. |
| Publication Type: | Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
